Form 4: Johnson & Johnson Sells CVRx, Inc. Shares

Johnson & Johnson, through its subsidiary JJDC, Inc., reported the sale of 1,000 shares of CVRx, Inc. common stock at a weighted average price of $10.00 per share.

Summary

• Johnson & Johnson, identified as a 10% owner and Director of CVRx, Inc., reported a transaction involving CVRx, Inc. common stock.
• The transaction occurred on November 12, 2025, and involved the disposition of 1,000 shares.
• The shares were sold at a weighted average price of $10.00 per share, with 29 shares sold at $10.04 and 971 shares sold at $10.00.
• Following this transaction, Johnson & Johnson, through its wholly-owned subsidiary Johnson & Johnson Innovation JJDC, Inc., indirectly beneficially owns 4,049,898 shares of CVRx, Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. This is a routine Form 4 filing reporting a small insider sale by a 10% owner and director. The transaction volume is negligible relative to the total holdings, suggesting it is unlikely to indicate a significant change in investment thesis or company outlook.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding CVRx, Inc.'s future performance or strategic direction.

Industry Context

This filing reports a routine insider transaction by a significant institutional investor and director, Johnson & Johnson, in a medical device company. Such transactions are common and typically reflect portfolio management decisions rather than specific industry trends, especially given the small volume relative to total holdings.

Related Party Transactions

• Johnson & Johnson, a 10% owner and director of CVRx, Inc., through its wholly-owned subsidiary Johnson & Johnson Innovation JJDC, Inc., sold 1,000 shares of CVRx, Inc. common stock.

Stakeholder Impact

• Shareholders: The sale of 1,000 shares by a significant institutional investor is a minor transaction and is unlikely to have a material impact on the company's stock price or investor sentiment.

Key Dates

Keywords

CVRx Inc, CVRX, Johnson & Johnson, JJDC Inc, Insider Trading, Form 4, Stock Sale, Beneficial Ownership